Aemetis (NASDAQ:AMTX) Share Price Crosses Below 200 Day Moving Average – Should You Sell?

Aemetis, Inc (NASDAQ:AMTX)’s stock price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $2.34 and traded as low as $1.3518. Aemetis shares last traded at $1.4140, with a volume of 356,142 shares.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the stock. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Aemetis in a research report on Wednesday, October 8th. Ascendiant Capital Markets cut their target price on shares of Aemetis from $21.00 to $20.00 and set a “buy” rating on the stock in a research note on Wednesday, November 19th. Three research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Aemetis presently has a consensus rating of “Moderate Buy” and a consensus price target of $17.00.

Aemetis Trading Up 2.5%

The stock has a market capitalization of $93.61 million, a price-to-earnings ratio of -0.88 and a beta of 2.29. The firm has a 50-day moving average of $1.89 and a 200 day moving average of $2.34.

Aemetis (NASDAQ:AMTX) last issued its quarterly earnings data on Friday, November 7th. The specialty chemicals company reported ($0.37) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.25) by ($0.12). The business had revenue of $59.19 million for the quarter, compared to the consensus estimate of $87.79 million. As a group, research analysts forecast that Aemetis, Inc will post -2.07 EPS for the current year.

Institutional Investors Weigh In On Aemetis

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Clear Harbor Asset Management LLC boosted its position in Aemetis by 31.0% in the 2nd quarter. Clear Harbor Asset Management LLC now owns 21,950 shares of the specialty chemicals company’s stock valued at $54,000 after buying an additional 5,200 shares during the last quarter. Vanguard Personalized Indexing Management LLC lifted its stake in shares of Aemetis by 48.7% in the second quarter. Vanguard Personalized Indexing Management LLC now owns 19,611 shares of the specialty chemicals company’s stock worth $49,000 after acquiring an additional 6,420 shares in the last quarter. Catalyst Funds Management Pty Ltd acquired a new position in shares of Aemetis in the second quarter worth about $25,000. R Squared Ltd purchased a new position in Aemetis in the second quarter valued at about $30,000. Finally, Creative Planning acquired a new stake in Aemetis during the 2nd quarter valued at approximately $30,000. Hedge funds and other institutional investors own 27.02% of the company’s stock.

Aemetis Company Profile

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.